BDBM41949 (E)-2-cyano-3-(1-phenyl-3-thiophen-2-yl-4-pyrazolyl)-N-prop-2-enyl-2-propenamide::(E)-2-cyano-3-(1-phenyl-3-thiophen-2-yl-pyrazol-4-yl)-N-prop-2-enyl-prop-2-enamide::(E)-2-cyano-3-(1-phenyl-3-thiophen-2-ylpyrazol-4-yl)-N-prop-2-enylprop-2-enamide::(E)-N-Allyl-2-cyano-3-(1-phenyl-3-thiophen-2-yl-1H-pyrazol-4-yl)-acrylamide::(E)-N-allyl-2-cyano-3-[1-phenyl-3-(2-thienyl)pyrazol-4-yl]acrylamide::MLS000588327::SMR000212142::cid_1902746
SMILES N1(C=NC=C1)C1=CC=C(C=N1)/C=C/C=1C=NC(=NC1)N1C[C@@H](N(CC1)C1=NC=C(C=N1)CF)COC
InChI Key InChIKey=HTSQIHHCUYPOOO-UHFFFAOYSA-N
Data 2 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 41949
Affinity DataKi: 1.10nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
Affinity DataKi: 1.20E+4nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
